Suppr超能文献

一种抗炎类固醇脂质体制剂作为眼部给药系统的疗效。

Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system.

作者信息

Taniguchi K, Itakura K, Yamazawa N, Morisaki K, Hayashi S, Yamada Y

机构信息

Research and Development Division, Rohto Pharmaceutical Co., Ltd., Osaka, Japan.

出版信息

J Pharmacobiodyn. 1988 Jan;11(1):39-46. doi: 10.1248/bpb1978.11.39.

Abstract

The efficacy of a liposome preparation on ocular steroid availability was investigated by both tracer studies and investigation of in vivo steroid uptake by the cornea. Dexamethasone and its ester derivatives were used as model drugs and aqueous suspensions of each served as control preparations. The liposome preparation containing dexamethasone valerate provided the highest ocular drug levels among the examined preparations. In the case of dexamethasone or dexamethasone palmitate, the liposomal form provided a lower drug level in comparison with the suspension. High esterase activity for dexamethasone valerate was observed in the corneal homogenate supernatant, and most of the steroid taken up after instillation of dexamethasone valerate was metabolized to free alcohol. The corneal dexamethasone level was almost proportional to the concentration of free dexamethasone valerate in the liposome preparation. Only the addition of stearylamine (SA) to the liposomal membrane had an added extra effect on the corneal absorption of dexamethasone valerate.

摘要

通过示踪研究以及对角膜体内类固醇摄取的研究,对脂质体制剂对眼部类固醇可用性的功效进行了调查。地塞米松及其酯衍生物用作模型药物,每种药物的水悬浮液用作对照制剂。在所检查的制剂中,含有戊酸地塞米松的脂质体制剂提供了最高的眼部药物水平。在地塞米松或棕榈酸地塞米松的情况下,脂质体形式与悬浮液相比提供了较低的药物水平。在角膜匀浆上清液中观察到戊酸地塞米松具有高酯酶活性,并且滴注戊酸地塞米松后摄取的大部分类固醇被代谢为游离醇。角膜地塞米松水平几乎与脂质体制剂中游离戊酸地塞米松的浓度成正比。仅在脂质体膜中添加硬脂胺(SA)对戊酸地塞米松的角膜吸收有额外的附加作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验